Profile data is unavailable for this security.
About the company
Gentian Diagnostics ASA is a Norway-based company within health care sector. The Company develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The Company is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.
- Revenue in NOK (TTM)142.22m
- Net income in NOK-5.83m
- Incorporated2001
- Employees58.00
- LocationGentian Diagnostics ASABjornasveien 5MOSS 1596NorwayNOR
- Websitehttps://www.gentian.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ContextVision AB | 135.27m | 32.90m | 464.85m | 38.00 | 14.13 | 5.36 | 11.24 | 3.44 | 0.4252 | 0.4252 | 1.75 | 1.12 | 1.23 | 2.55 | 3.81 | 3,381,650.00 | 29.83 | 29.39 | 39.15 | 43.27 | 98.08 | 98.58 | 24.32 | 27.15 | 3.40 | -- | 0.044 | -- | 12.19 | 7.78 | -1.77 | -- | -35.88 | -- |
| Acarix AB | 5.87m | -76.76m | 479.78m | 9.00 | -- | 4.58 | -- | 81.67 | -0.1431 | -0.1431 | 0.0103 | 0.1069 | 0.0821 | 0.1257 | 3.51 | -- | -107.29 | -66.93 | -125.57 | -77.12 | 86.04 | 79.42 | -1,306.54 | -1,483.68 | 6.88 | -312.95 | 0.00 | -- | 7.20 | 43.55 | -1.11 | -- | -- | -- |
| Modulight Oyj | -1.14tn | -1.14tn | 553.27m | 70.00 | -- | 0.9023 | -- | -- | -- | -- | -- | 1.26 | -- | -- | -- | -- | -- | -8.39 | -- | -9.10 | -- | 114.69 | -- | -56.81 | 6.11 | -- | 0.1004 | -- | -12.48 | -8.20 | -38.69 | -- | 63.60 | -- |
| BrainCool AB (publ) | 29.32m | -57.40m | 563.43m | 22.00 | -- | 4.61 | -- | 19.21 | -0.2848 | -0.2848 | 0.1465 | 0.4792 | 0.2418 | 2.09 | 3.32 | 1,214,417.00 | -47.34 | -47.14 | -56.18 | -70.16 | -50.61 | -149.77 | -195.75 | -391.45 | 0.7253 | -7.34 | 0.00 | -- | 32.06 | 78.35 | -34.34 | -- | -11.63 | -- |
| Bioretec Oy | 44.49m | -43.15m | 664.68m | 37.00 | -- | 6.81 | -- | 14.94 | -0.1984 | -0.1984 | 0.2047 | 0.4213 | 0.5524 | 1.46 | 3.68 | 105,594.60 | -53.58 | -67.11 | -65.75 | -97.60 | 69.85 | 70.97 | -96.98 | -134.05 | 4.86 | -4.02 | 0.0754 | -- | 32.77 | 19.77 | -56.82 | -- | -- | -- |
| Omda AS | 416.87m | 88.33m | 752.59m | 291.00 | 8.43 | 8.61 | 4.75 | 1.81 | 4.27 | 4.27 | 20.44 | 4.18 | 0.5534 | 168.94 | 10.73 | 1,432,536.00 | 12.70 | -4.92 | 16.78 | -6.37 | 92.56 | 90.22 | 22.96 | -9.83 | 1.25 | 2.58 | 0.8487 | -- | 12.30 | 19.83 | 179.30 | -- | -3.93 | -- |
| Senzime AB (publ) | 40.83m | -132.08m | 758.88m | 52.00 | -- | 2.54 | -- | 18.58 | -1.30 | -1.30 | 0.3902 | 2.95 | 0.1045 | 1.34 | 5.80 | -- | -33.80 | -35.69 | -35.58 | -38.00 | 26.75 | -20.59 | -323.45 | -558.68 | 5.85 | -- | 0.0308 | -- | 154.77 | 61.90 | -1.09 | -- | -3.69 | -- |
| Mentice AB | 255.63m | -26.13m | 779.49m | 128.00 | -- | 5.71 | 1,889.60 | 3.05 | -1.01 | -1.01 | 10.03 | 5.30 | 0.8435 | 1.97 | 3.88 | 2,082,557.00 | -8.62 | -7.69 | -17.02 | -13.07 | 87.57 | 83.67 | -10.22 | -10.00 | 0.8586 | -- | 0.0553 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| Gentian Diagnostics ASA | 142.22m | -5.83m | 879.07m | 58.00 | -- | 5.81 | 245.55 | 6.18 | -0.3783 | -0.3783 | 9.22 | 9.82 | 0.7646 | 1.85 | 6.35 | 2,452,035.00 | -3.14 | -10.76 | -3.58 | -11.86 | 50.84 | 41.46 | -4.10 | -26.99 | 4.14 | -- | 0.0555 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
| OssDsign AB | 118.44m | -119.12m | 906.92m | 48.00 | -- | 4.02 | -- | 7.66 | -1.51 | -1.51 | 1.40 | 2.30 | 0.3907 | 3.60 | 6.62 | 2,452,500.00 | -39.29 | -37.92 | -43.39 | -43.56 | 77.15 | 68.10 | -100.57 | -203.06 | 5.18 | -36.90 | 0.013 | -- | 96.84 | 53.26 | -31.30 | -- | -56.16 | -- |
| Nightingale Health Oyj | 41.61m | -205.66m | 911.96m | 81.00 | -- | 1.34 | -- | 21.92 | -0.2979 | -0.2979 | 0.0603 | 1.50 | 0.0344 | 1.60 | 3.87 | 44,560.98 | -17.02 | -14.20 | -18.12 | -15.69 | 75.81 | 83.57 | -494.25 | -408.50 | 14.15 | -- | 0.0378 | -- | 80.80 | 19.05 | -12.38 | -- | -- | -- |
| Paxman AB (publ) | 227.81m | 24.12m | 1.03bn | 94.00 | 42.91 | 7.55 | 24.12 | 4.53 | 1.26 | 1.26 | 11.89 | 7.16 | 1.28 | 2.66 | 6.46 | 2,488,099.00 | 13.59 | -5.08 | 18.38 | -7.76 | 69.47 | 69.38 | 10.59 | -5.07 | 1.76 | -- | 0.1122 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
| Integrum AB | 104.76m | 4.20m | 1.08bn | 36.00 | 261.09 | 7.06 | 169.84 | 10.34 | 0.2199 | 0.2199 | 5.55 | 8.13 | 0.6307 | 0.5919 | 3.80 | 2,892,222.00 | 2.53 | 0.7612 | 2.80 | 0.8818 | 87.65 | 83.87 | 4.01 | 1.28 | 3.32 | -- | 0.043 | -- | 40.19 | 35.91 | 212.14 | -- | 127.10 | -- |
| SyntheticMR AB (publ) | 91.41m | 15.77m | 1.15bn | 38.00 | 71.76 | 9.47 | 51.50 | 12.53 | 0.3804 | 0.3804 | 2.21 | 2.88 | 0.6719 | -- | 1.58 | 2,455,541.00 | 11.59 | 7.19 | 13.87 | 8.85 | 73.94 | 69.70 | 17.25 | 9.08 | -- | -- | 0.0083 | 21.50 | 30.67 | 13.05 | 70.34 | -7.33 | 27.30 | -- |
| Optomed Oyj | 170.24m | -49.80m | 1.28bn | 114.00 | -- | 5.31 | -- | 7.54 | -0.2575 | -0.2575 | 0.8872 | 1.08 | 0.5199 | 1.70 | 3.94 | 131,131.60 | -15.21 | -12.95 | -18.59 | -15.90 | 66.76 | 65.69 | -29.25 | -27.84 | 1.72 | -12.96 | 0.1894 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
Data as of Jul 03 2024. Currency figures normalised to Gentian Diagnostics ASA's reporting currency: Norwegian Krone NOK
33.99%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Vatne Capital ASas of 30 Apr 2024 | 2.33m | 15.11% |
| Storebrand Asset Management ASas of 31 Jan 2024 | 1.47m | 9.51% |
| DNB Asset Management ASas of 30 Apr 2024 | 359.03k | 2.33% |
| Schroder Investment Management Ltd.as of 31 Dec 2023 | 350.00k | 2.27% |
| Rasmussengruppen ASas of 30 Apr 2024 | 320.92k | 2.08% |
| Equinor Asset Management ASAas of 31 Dec 2023 | 245.05k | 1.59% |
| Norron ABas of 31 May 2024 | 169.66k | 1.10% |
More ▼
Data from 31 Dec 2023 - 31 May 2024Source: FactSet Research Systems Inc.
